Skip to main content
Clinical Trials/NCT01484717
NCT01484717
Completed
Phase 2

Interactive Voice Response Technology to Mobilize Contingency Management for Smoking Cessation

UConn Health1 site in 1 country90 target enrollmentJanuary 2012

Overview

Phase
Phase 2
Intervention
transdermal nicotine
Conditions
Cigarette Smoking
Sponsor
UConn Health
Enrollment
90
Locations
1
Primary Endpoint
Longest duration of abstinence
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

Cigarette smoking remains the most common source of preventable morbidity and mortality in the United States, with in excess of $167 billion in economic costs per year. Contingency management (CM), in which tangible incentives are provided contingent on a target behavior like abstinence, is highly efficacious in improving substance abuse treatment outcomes and is receiving increased attention for smoking cessation. Expired carbon monoxide (CO) is the most common objective smoking status test used in smoking research and treatment. Unfortunately, multiple CO tests/day are typically required to detect all smoking and reinforce sustained abstinence. The resulting logistical and resource limitations greatly limit the application of this potentially powerful quit smoking toolset. This study addresses these limitations by examining the effectiveness of using interactive voice response technology (IVR) to implement CM. Smokers who want to quit (N = 90 randomized) will receive 2 quit preparation sessions based on public health guidelines for smoking cessation and set a target quit date. Participants will be randomly assigned to 1 of 2 treatment conditions: (a) IVR-S consisting of objective smoking status monitoring using IVR, telephone counseling and transdermal nicotine and (b) IVR-CM, consisting of the same monitoring, telephone counseling and transdermal nicotine plus IVR-based CM for smoking abstinence. It is hypothesized that abstinence rates will be higher in the IVR-CM condition compared to the IVR-S, supporting a combined IVR CM approach, and thereby greatly increasing the applicability of these powerful smoking cessation tools.

Registry
clinicaltrials.gov
Start Date
January 2012
End Date
December 2014
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
UConn Health
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • regular cigarette smoker
  • mailing address \& valid photo I.D.
  • want transdermal nicotine

Exclusion Criteria

  • not English speaking
  • in recovery for pathological gambling
  • contraindication for transdermal nicotine
  • female who is pregnant, nursing a child, or not using effective contraception

Arms & Interventions

Standard Care

Telephone counseling plus nicotine patch

Intervention: transdermal nicotine

Standard Care

Telephone counseling plus nicotine patch

Intervention: Telephone counseling

Contingency management for abstinence from cigarettes

Telephone counseling and nicotine patch plus contingency management

Intervention: contingency management for smoking abstinence

Contingency management for abstinence from cigarettes

Telephone counseling and nicotine patch plus contingency management

Intervention: transdermal nicotine

Contingency management for abstinence from cigarettes

Telephone counseling and nicotine patch plus contingency management

Intervention: Telephone counseling

Outcomes

Primary Outcomes

Longest duration of abstinence

Time Frame: Week 24

Study Sites (1)

Loading locations...

Similar Trials